No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Inspiration Healthcare reported a 24% rise in revenue to 47.5m for the year ended 31 January on Tuesday, supported by strong growth in SLE products and 9.5m of one-off export revenues.
The AIM-traded neonatal medical technology group said gross profit rose 27% to 20.8m, while adjusted EBITDA improved to 2.8m from 0.2m and adjusted operating profit was 0.8m, compared with a 1.9m loss a year earlier.
Its operating loss narrowed to 0.1m from 14.7m, while net debt excluding leases fell 39% to 5.1m.
Chief executive Raffi Stepanian said FY26 had been a "transformational year" as the group moved from stabilisation to growth execution.
Inspiration said current trading was in line with board expectations for FY27, with its order book and opportunity pipeline supporting confidence in meeting full-year market forecasts.
At 1109 BST, shares in Inspiration Healthcare Group were up 7.31% at 27.9p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.